Guselkumab in the Treatment of Pityriasis Rubra Pilaris (PRP)

NCT03975153 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
15
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Oregon Health and Science University